Sunday, November 1, 2026

Deckers Selects E-Land as HOKA’s New Exclusive Distributor in Korea, Signaling Dispute With Joyworks

Deckers has named E-Land as HOKA’s new exclusive distributor in South Korea, setting the stage for a potential legal dispute with existing distributor Joyworks.

Kim Jong Un Visits Grandfather’s Tomb to Mark 31 Years Since His Death

Kim Jong Un commemorates Kim Il Sung's death anniversary at Kumsusan Palace, affirming his predecessors' legacy amidst national remembrance.

GC Biopharma Unveils mRNA Vaccine Strategy at Seoul Pandemic X Summit 2026: What’s Next for COVID-19?

GC Biopharma presents its mRNA vaccine strategy at the Seoul Pandemic X Summit 2026, focusing on rapid responses to future pandemics.

News1

Author's Latest

Unlocking Growth: How Biopharmaceuticals’ Cenobamate is Transforming Epilepsy Treatment in Asia

SK Biopharmaceuticals' epilepsy drug Cenobamate is expected to continue its growth trend in the second half of the year.

Strengthening U.S.-Korea Collaboration: AI, Space, and Quantum Innovations at UKC 2026

South Korea aims to enhance joint research and personnel exchanges with the U.S. in AI, space, and quantum technology.

Drinking to Cope With Emotional Pain May Raise Depression Risk: “Only Harms Your Health”

Drinking to cope with trauma may worsen depression over time by weakening the brain’s ability to regulate stress.

AI to Fill Gaps in Regional and Essential Healthcare, Raising Hopes for a Major Shift in the Medical Device Market

South Korea's new AI healthcare strategy is expected to accelerate adoption of AI across public and essential healthcare, creating new growth opportunities for medical AI, healthcare IT and AI drug development companies.

How the SIALAP System Revolutionizes Preclinical Trials for Drug-Resistant Epilepsy

Researchers developed an objective framework for matching animal models to specific types of drug-resistant epilepsy, potentially improving the accuracy of preclinical drug development.

Is Your Food Safe? 5 Key Insights on Rising Salmonella and Norovirus Cases

Salmonella food poisoning has increased for five consecutive years, with nearly 10,000 cases reported last year.

LG Group’s CEO to Meet NVIDIA’s Jensen Huang: What Could This Mean for AI and Robotics Collaboration?

LG Group's Koo Kwang-mo will meet Nvidia CEO Jensen Huang in Silicon Valley next week, two months after their last meeting.

Unlocking Gut Health: HP7 Probiotics vs. Postbiotics – What You Need to Know

Hy published research on its patented probiotic HP7 in the prestigious SCI journal JMB, highlighting its significance in gut health.

FDA Adjusts Drug Review Fees: Higher for New Drugs, Lower for Generics

The FDA’s 2027 fee changes lower review costs for new drugs and biosimilars while raising fees for generics and medical devices, with the impact varying by company.

GIST Develops “Alpha DTA” AI Model to Accurately Predict Drug Candidate Potency

GIST's AI model 'Alpha DTA' predicts drug-target protein binding affinity without experimental verification, enhancing drug discovery.

Shaperon Accelerates Global Commercialization of NuGel…Secures U.S. Patent, Prepares for Licensing Deal

Sharperon accelerates global commercialization of its key atopic dermatitis treatment, NuGel.

“Why Can’t Stem Cell Treatments Be Offered in Korea?”…Government Maps Out a “Korean Model of Regenerative Medicine”

The debate over stem cell therapy highlights why it's available in Japan but not in South Korea.

Yuhan Corp., Celltrion and LigaChem Bio…K-Pharma Firms Move to Boost Corporate Value

The pharmaceutical and biotech sectors are boosting shareholder trust and corporate value through stock buybacks and retirements.

PenetriumBioScience Files U.S. FDA IND for Phase 2a Trial in Advanced Solid Tumors

Penitrium Bioscience enters Phase 2a clinical trials in the U.S. for its cancer drug candidate 'Penitrium.'

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.